Home › Compare › BPCP vs JNJ

BPCP vs JNJ: Dividend Comparison 2026

BPCP yields 29100.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPCP wins by $2.181048452443935e+21M in total portfolio value
10 years
BPCP
BPCP
● Live price
29100.00%
Share price
$0.03
Annual div
$8.73
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.181048452443935e+21M
Annual income
$2,166,403,628,259,168,600,000,000,000.00
Full BPCP calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BPCP vs JNJ

📍 BPCP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPCPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPCP + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BPCP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPCP
Annual income on $10K today (after 15% tax)
$2,473,500.00/yr
After 10yr DRIP, annual income (after tax)
$1,841,443,084,020,293,100,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BPCP beats the other by $1,841,443,084,020,293,100,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPCP + JNJ for your $10,000?

BPCP: 50%JNJ: 50%
100% JNJ50/50100% BPCP
Portfolio after 10yr
$1.0905242262219675e+21M
Annual income
$1,083,201,814,129,584,300,000,000,000.00/yr
Blended yield
99.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BPCP
No analyst data
Altman Z
-0.2
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPCP buys
0
JNJ buys
0
No recent congressional trades found for BPCP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPCPJNJ
Forward yield29100.00% ✓3.36%
Annual dividend / share$8.73 ✓$4.96
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$2.181048452443935e+21M$20.0K ✓
Annual income after 10y$2,166,403,628,259,168,600,000,000,000.00 ✓$827.78
Total dividends collected$2.18008472748864e+21M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BPCP vs JNJ ($10,000, DRIP)

YearBPCP PortfolioBPCP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,920,700$2,910,000.00$10,676$355.77+$2.91M → BPCP
2$797,446,364$794,321,214.95$11,407$389.39+$797.43M → BPCP
3$203,540,744,167$202,687,476,557.26$12,198$426.53+$203540.73M → BPCP
4$48,567,402,897,557$48,349,614,301,298.39$13,056$467.62+$48567402.88M → BPCP
5$10,834,052,308,549,964$10,782,085,187,449,578.00$13,987$513.12+$10834052308.54M → BPCP
6$2,259,430,539,035,731,700$2,247,838,103,065,582,800.00$14,998$563.56+$2259430539035.72M → BPCP
7$440,533,795,929,311,300,000$438,116,205,252,543,000,000.00$16,098$619.52+$440533795929311.25M → BPCP
8$80,304,982,704,211,880,000,000$79,833,611,542,567,520,000,000.00$17,295$681.69+$80304982704211872.00M → BPCP
9$13,686,751,574,548,174,000,000,000$13,600,825,243,054,670,000,000,000.00$18,599$750.82+$13686751574548174848.00M → BPCP
10$2,181,048,452,443,935,200,000,000,000$2,166,403,628,259,168,600,000,000,000.00$20,022$827.78+$2.181048452443935e+21M → BPCP

BPCP vs JNJ: Complete Analysis 2026

BPCP — Stock

Bishop Capital Corporation, through its subsidiaries, engages in the development and sale of real estate properties in the United States. The company owns and operates a 328 unit apartment complex located in Colorado Springs, Colorado. It also owns approximately 2 acres of developed and 16 acres of undeveloped land in Colorado. The company is developing a 16 acre parcel called The Crossing at Palmer Park and 11 acre parcel called Creekside Center at Galley. In addition, it has a royalty interest in a natural gas property located in Wyoming. Bishop Capital, formerly known as Bishop Cable Communications Corporation, was incorporated in 1983 and changed its name to Bishop Capital Corporation in 1995. The company is based in Riverton, Wyoming.

Full BPCP Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BPCP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPCP vs SCHDBPCP vs JEPIBPCP vs OBPCP vs KOBPCP vs MAINBPCP vs ABBVBPCP vs MRKBPCP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.